Connection

IHAB HAJJAR to Atomoxetine Hydrochloride

This is a "connection" page, showing publications IHAB HAJJAR has written about Atomoxetine Hydrochloride.
Connection Strength

0.046
  1. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain. 2022 06 30; 145(6):1924-1938.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.